175 related articles for article (PubMed ID: 22088929)
1. Increased risk of cancer among gout patients: a nationwide population study.
Kuo CF; Luo SF; See LC; Chou IJ; Fang YF; Yu KH
Joint Bone Spine; 2012 Jul; 79(4):375-8. PubMed ID: 22088929
[TBL] [Abstract][Full Text] [Related]
2. Association of gout and colorectal cancer in Taiwan: a nationwide population-based cohort study.
Chuang JP; Lee JC; Leu TH; Hidajah AC; Chang YH; Li CY
BMJ Open; 2019 Oct; 9(10):e028892. PubMed ID: 31601586
[TBL] [Abstract][Full Text] [Related]
3. Long-term allopurinol use decreases the risk of prostate cancer in patients with gout: a population-based study.
Shih HJ; Kao MC; Tsai PS; Fan YC; Huang CJ
Prostate Cancer Prostatic Dis; 2017 Sep; 20(3):328-333. PubMed ID: 28398294
[TBL] [Abstract][Full Text] [Related]
4. Colchicine Significantly Reduces Incident Cancer in Gout Male Patients: A 12-Year Cohort Study.
Kuo MC; Chang SJ; Hsieh MC
Medicine (Baltimore); 2015 Dec; 94(50):e1570. PubMed ID: 26683907
[TBL] [Abstract][Full Text] [Related]
5. Cancer risk in Korean patients with gout.
Oh YJ; Lee YJ; Lee E; Park B; Kwon JW; Heo J; Moon KW
Korean J Intern Med; 2022 Mar; 37(2):460-467. PubMed ID: 32872748
[TBL] [Abstract][Full Text] [Related]
6. Gout can increase the risk of periodontal disease in Taiwan.
Chen HH; Ho CW; Hsieh MC; Chen CC; Hsu SP; Lin CL; Kao CH
Postgrad Med; 2020 Aug; 132(6):521-525. PubMed ID: 32298158
[No Abstract] [Full Text] [Related]
7. Association between colchicine use and the risk of dementia among patients with gout: A nationwide retrospective cohort study.
Chen PY; Tseng CC; Lee YT; Yip HT; Chang R; Wei JC
Int J Rheum Dis; 2024 May; 27(5):e15162. PubMed ID: 38720421
[TBL] [Abstract][Full Text] [Related]
8. Gout and a Subsequent Increased Risk of Erectile Dysfunction in Men Aged 64 and Under: A Nationwide Cohort Study in Taiwan.
Chen YF; Lin HH; Lu CC; Hung CT; Lee MH; Hsu CY; Chung WS
J Rheumatol; 2015 Oct; 42(10):1898-905. PubMed ID: 26077405
[TBL] [Abstract][Full Text] [Related]
9. Risk of incident gout in kidney transplant recipients: A retrospective cohort study.
Simbolon FR; Lee SS; Tsai YC; Tsai WC; Lin GT; Tung YC; Tu HP
Int J Rheum Dis; 2018 Nov; 21(11):1993-2001. PubMed ID: 30338664
[TBL] [Abstract][Full Text] [Related]
10. Comorbidity in gout at the time of first diagnosis: sex differences that may have implications for dosing of urate lowering therapy.
Drivelegka P; Sigurdardottir V; Svärd A; Jacobsson LTH; Dehlin M
Arthritis Res Ther; 2018 Jun; 20(1):108. PubMed ID: 29855389
[TBL] [Abstract][Full Text] [Related]
11. Allopurinol and the incidence of bladder cancer: a Taiwan national retrospective cohort study.
Chen CJ; Hsieh MC; Liao WT; Chan YT; Chang SJ
Eur J Cancer Prev; 2016 May; 25(3):216-23. PubMed ID: 25830898
[TBL] [Abstract][Full Text] [Related]
12. Urate-lowering treatment and risk of total joint replacement in patients with gout.
Kuo CF; Chou IJ; See LC; Chen JS; Yu KH; Luo SF; Hsieh AH; Zhang W; Doherty M
Rheumatology (Oxford); 2018 Dec; 57(12):2129-2139. PubMed ID: 30060176
[TBL] [Abstract][Full Text] [Related]
13. Allopurinol and the risk of prostate cancer in a Finnish population-based cohort.
Kukko V; Kaipia A; Talala K; Taari K; Tammela TLJ; Auvinen A; Murtola TJ
Prostate Cancer Prostatic Dis; 2019 Sep; 22(3):483-490. PubMed ID: 30696944
[TBL] [Abstract][Full Text] [Related]
14. Gout drugs use and risk of cancer: A case-control study.
Yang HC; Nguyen PAA; Islam M; Huang CW; Poly TN; Iqbal U; Li YJ
Joint Bone Spine; 2018 Dec; 85(6):747-753. PubMed ID: 29427783
[TBL] [Abstract][Full Text] [Related]
15. Risk of end-stage renal disease associated with gout: a nationwide population study.
Yu KH; Kuo CF; Luo SF; See LC; Chou IJ; Chang HC; Chiou MJ
Arthritis Res Ther; 2012 Apr; 14(2):R83. PubMed ID: 22513212
[TBL] [Abstract][Full Text] [Related]
16. Risk of myocardial infarction among patients with gout: a nationwide population-based study.
Kuo CF; Yu KH; See LC; Chou IJ; Ko YS; Chang HC; Chiou MJ; Luo SF
Rheumatology (Oxford); 2013 Jan; 52(1):111-7. PubMed ID: 22787006
[TBL] [Abstract][Full Text] [Related]
17. Frequency and risk factors of gout flares in a large population-based cohort of incident gout.
Rothenbacher D; Primatesta P; Ferreira A; Cea-Soriano L; Rodríguez LA
Rheumatology (Oxford); 2011 May; 50(5):973-81. PubMed ID: 21228059
[TBL] [Abstract][Full Text] [Related]
18. Epidemiology and management of gout in Taiwan: a nationwide population study.
Kuo CF; Grainge MJ; See LC; Yu KH; Luo SF; Zhang W; Doherty M
Arthritis Res Ther; 2015 Jan; 17(1):13. PubMed ID: 25612613
[TBL] [Abstract][Full Text] [Related]
19. Management of gout in the older adult.
Fravel MA; Ernst ME
Am J Geriatr Pharmacother; 2011 Oct; 9(5):271-85. PubMed ID: 21849262
[TBL] [Abstract][Full Text] [Related]
20. Adherence and persistence to urate-lowering therapies in the Irish setting.
McGowan B; Bennett K; Silke C; Whelan B
Clin Rheumatol; 2016 Mar; 35(3):715-21. PubMed ID: 25409858
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
